Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kotra Industries BhdXKLS:0002 +1.35%83 Cash Ratio is 0.84 as of Mar. 2026, which is 8% below its 10-year median of 0.91. GuruFocus rates XKLS:0002 with a GF Score™ of 83/100 and a GF Value™ of RM4.35 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 975 Drug Manufacturers companies, Kotra Industries Bhd ranks better than 57.64% on this metric.
Kotra Industries Bhd has a Cash Ratio of 0.84. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Kotra Industries Bhd's Cash Ratio or its related term are showing as below:
XKLS:0002'
s Cash Ratio Range Over the Past 10 Years
Min: 0.26 Med: 0.91 Max: 1.9
Current: 0.84
During the past 13 years, Kotra Industries Bhd's highest Cash Ratio was 1.90. The lowest was 0.26. And the median was 0.91.
XKLS:0002's Cash Ratio is ranked better than 57.64% of 975
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs XKLS:0002: 0.84
Kotra Industries Bhd (XKLS:0002) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Kotra Industries Bhd Cash Ratio Related Terms
Kotra Industries Bhd Cash Ratio Historical Data
* Premium members only.
The historical data trend for Kotra Industries Bhd's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0002 vs ZTS, UTHR, VTRS: Cash Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kotra Industries Bhd's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kotra Industries Bhd Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kotra Industries Bhd's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Kotra Industries Bhd's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kotra Industries Bhd (XKLS:0002) has a Cash Ratio of 0.84 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Kotra Industries Bhd and its competitors. This is near median its historical median of 0.91. Over the past decade, Kotra Industries Bhd's Cash Ratio has ranged from 0.26 to 1.90. According to the industry distribution chart, Kotra Industries Bhd ranks #413 out of 975 companies in the Drug Manufacturers industry, placing it in the top 42.4%.
Is Kotra Industries Bhd's Cash Ratio too high?
Kotra Industries Bhd's current Cash Ratio of 0.84 is near median its 10-year median of 0.91. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 1.90. The Drug Manufacturers industry median Cash Ratio is 0.60. Kotra Industries Bhd's value of 0.84 is 40% above this industry median. Based on the distribution chart, Kotra Industries Bhd ranks #413 out of 975 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Kotra Industries Bhd has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's Cash Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kotra Industries Bhd ranks #413 out of 975 companies for Cash Ratio. This puts Kotra Industries Bhd in the upper half of its industry. The industry median Cash Ratio is 0.60. Kotra Industries Bhd's value of 0.84 is 40% above this benchmark. Historically, Kotra Industries Bhd's own Cash Ratio has ranged from 0.26 to 1.90 over the past decade. While the company's 10-year median is 0.91 vs. the industry median of 0.60, Kotra Industries Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.60, based on 975 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kotra Industries Bhd's current Cash Ratio of 0.84 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Kotra Industries Bhd and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kotra Industries Bhd's current Cash Ratio is 0.84, which is near median its own 10-year median of 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.35, compared to a current price of RM3.75 — trading 13.8% below its estimated fair value. The current Cash Ratio is 0.84, which is near median its 10-year median of 0.91 and 40% above the Drug Manufacturers industry median of 0.60. Kotra Industries Bhd's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current Cash Ratio is 0.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?
Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued.
The current stock price of RM3.75 is trading 13.8% below its estimated GF Value™ of RM4.35.
GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0002:
Cash Ratio: 0.84 (near median its 10-year median of 0.91)
GF Value™: RM4.35 vs. price of RM3.75 (13.8% below fair value)
Industry Position: 40% above the Drug Manufacturers median (#413 of 975)
No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
83GF Score
Get the complete analysis for XKLS:0002
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0002 has been successfully added to your 
